There is more hope than ever surrounding the diagnosis and treatment of dementia. Take care of your brain health and talk to ...

We all know about Alzheimer’s Disease, in fact, many of us know someone who has been impacted by it. But there is another ...

An FDA-approved synthetic THC significantly reduces agitation in Alzheimer's patients, improving treatment outcomes and ...

AG03, developed by researchers at the University of Southampton, targets two critical regions of the tau protein linked to ...

Nearly seven million Americans are living with Alzheimer’s disease – a leading cause of death in the United States.

AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.

We spoke to Andrew Doig, professor of biochemistry at the University of Manchester, to find out more about the evolving ...

The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement.

While Alzheimer’s can’t be reversed, Leqembi has proven that it can slow down the progression of the disease.

Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer's ...

Summary: A new study finds that brain shrinkage in Alzheimer’s patients does not follow a uniform pattern. Researchers ...